98 related articles for article (PubMed ID: 20381320)
1. Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Burkhardt O; Thon S; Burhenne J; Welte T; Kielstein JT
Int J Antimicrob Agents; 2010 Jul; 36(1):93-4. PubMed ID: 20381320
[No Abstract] [Full Text] [Related]
2. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
von Mach MA; Burhenne J; Weilemann LS
BMC Clin Pharmacol; 2006 Sep; 6():6. PubMed ID: 16981986
[TBL] [Abstract][Full Text] [Related]
3. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Mohammedi I; Piens MA; Padoin C; Robert D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Groll AH; Kolve H; Ehlert K; Paulussen M; Vormoor J
J Antimicrob Chemother; 2004 Jan; 53(1):113-4. PubMed ID: 14657088
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole.
Med Lett Drugs Ther; 2002 Jul; 44(1135):63-5. PubMed ID: 12138377
[No Abstract] [Full Text] [Related]
8. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
[TBL] [Abstract][Full Text] [Related]
9. [Update on voriconazole].
Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
[No Abstract] [Full Text] [Related]
10. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
[TBL] [Abstract][Full Text] [Related]
11. The effect of enteral nutrition supplements on serum voriconazole levels.
Williams D
J Oncol Pharm Pract; 2012 Mar; 18(1):128-31. PubMed ID: 21733905
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
Cudillo L; Girmenia C; Santilli S; Picardi A; Dentamaro T; Tendas A; de Fabritiis P
Clin Infect Dis; 2005 Apr; 40(8):1212-3. PubMed ID: 15791530
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
Luke DR; Wood ND; Tomaszewski KE; Damle B
Nephrol Dial Transplant; 2012 Mar; 27(3):1207-12. PubMed ID: 21868395
[TBL] [Abstract][Full Text] [Related]
14. What is the "therapeutic range" for voriconazole?
Lewis RE
Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
[No Abstract] [Full Text] [Related]
15. High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Alffenaar JW; Doedens RA; Groninger E; Kosterink JG
Pediatr Infect Dis J; 2008 Feb; 27(2):189-90. PubMed ID: 18174859
[No Abstract] [Full Text] [Related]
16. A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
Lombardi LR; Miano TA; Davis JL; Morgan SC; Goldstein SC; Vardhanabhuti S; Mitra N; Vozniak JM
J Oncol Pharm Pract; 2012 Mar; 18(1):3-9. PubMed ID: 21350019
[TBL] [Abstract][Full Text] [Related]
17. Random plasma concentrations of voriconazole decline over time.
Mulanovich V; Lewis RE; Raad II; Kontoyiannis DP
J Infect; 2007 Nov; 55(5):e129-30. PubMed ID: 17804077
[TBL] [Abstract][Full Text] [Related]
18. [Role of voriconazole in critically ill patients with invasive mycoses].
Alvarez Lerma F
Rev Iberoam Micol; 2007 Sep; 24(3):209-12. PubMed ID: 17874857
[TBL] [Abstract][Full Text] [Related]
19. [Voriconazole: a new weapon against invasive fungal infections].
Aoun M
Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Ullmann AJ; Heussel CP; Cornely OA
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
